Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pediatric Expansion Study of the Sentio System

NCT: NCT06976086 · ACTIVE_NOT_RECRUITING

NCT IDNCT06976086
StatusACTIVE_NOT_RECRUITING
Start Date2025-04-30
Completion2027-07-01
SponsorOticon Medical (INDUSTRY)
First posted
Last updated

Brief Summary

This study is performed to collect safety and performance data supporting the use of the Sentio system in children below 12 years of age. The system is currently available on the market for patients 12 years and above. It is a prospective study conducted at eight European hospitals, aiming to treat 50 patients with a hearing loss than would benefit from treatment with a bone-anchored hearing system (BAHS). The primary objective of the study is to demonstrate that the Sentio system improves the hearing on the implanted ear, compared with the unaided situation.

Frequently Asked Questions

What is Pediatric Expansion Study of the Sentio System?

Pediatric Expansion Study of the Sentio System is a clinical trial registered under NCT06976086. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06976086?

The current status of NCT06976086 (Pediatric Expansion Study of the Sentio System) is: ACTIVE_NOT_RECRUITING.

When did Pediatric Expansion Study of the Sentio System start?

Pediatric Expansion Study of the Sentio System started on 2025-04-30.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.